Roopal Thakkar is SVP, CMO, GLOBAL THERAPEUTICS of AbbVie Inc.. Currently has a direct ownership of 23,259 shares of ABBV, which is worth approximately $4.56 Million. The most recent transaction as insider was on Feb 28, 2024, when has been sold 4,914 shares (Common Stock, $0.01 par value) at a price of $178.99 per share, resulting in proceeds of $879,556. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.3K
0% 3M change
n/a 12M change
Total Value Held $4.56 Million

Roopal Thakkar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2024
SELL
Payment of exercise price or tax liability
$879,556 $178.99 p/Share
4,914 Reduced 17.44%
23,259 Common Stock, $0.01 pa...
Feb 15 2024
BUY
Grant, award, or other acquisition
-
17,796 Added 38.71%
28,173 Common Stock, $0.01 pa...
RT

Roopal Thakkar

SVP, CMO, GLOBAL THERAPEUTICS
North Chicago, IL

Track Institutional and Insider Activities on ABBV

Follow AbbVie Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABBV shares.

Notify only if

Insider Trading

Get notified when an Abb Vie Inc. insider buys or sells ABBV shares.

Notify only if

News

Receive news related to AbbVie Inc.

Track Activities on ABBV